Staff,
Department of Pharmaceutical Sciences
St. Jude Children's Research Hospital
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen I-M, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz M, Pui C-H, Smith M, Hunger SP, Willman C, Downing JR, and the Children's Oncology Group
N Engl J Med 2009;360:470-80.*
*See also: ALL-SNP4
Treatment-specific Changes in Gene Expression Discriminate in vivo Drug response in Human Leukemia Cells.
Meyling H. Cheok, Wenjian Yang, Ching Hon Pui, James R. Downing, Cheng Cheng, Clayton W. Naeve, Mary V. Relling, William E. Evans
Nature Genetics 2003 Jun;34(2):231.